Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine

Area of Science:

• Emergency Medicine
• Neurology
• Pharmacology

Background:

• Dexamethasone is used to prevent migraine recurrence after emergency department (ED) visits.
• The optimal dosage of dexamethasone for this purpose remains unclear.
• This study aimed to compare the efficacy of two different intravenous (IV) dexamethasone doses.

Purpose of the Study:

• To determine if a higher dose of intravenous dexamethasone (16 mg) provides greater sustained headache relief than a lower dose (4 mg) when administered with metoclopramide in ED migraine patients.
• To evaluate secondary outcomes including short-term headache relief and headache recurrence within seven days.

Main Methods:

• A randomized, double-blind study involving 209 adult patients with moderate to severe migraine.
• Patients received either 4 mg or 16 mg of IV dexamethasone coadministered with 10 mg IV metoclopramide.
• Headache intensity was assessed in the ED and via telephone at 48 hours and 7 days post-discharge.

Main Results:

• Sustained headache relief was achieved by 34% of patients in the 4 mg arm and 41% in the 16 mg arm (absolute difference 7%, 95% CI -6% to 20%).
• Headache relief within 2 hours was similar: 74% in the low-dose group and 78% in the high-dose group (absolute difference 4%, 95% CI -8% to 16%).
• Median headache days in the week following discharge were 2 for both groups.

Conclusions:

• Intravenous dexamethasone doses higher than 4 mg are unlikely to offer additional benefit for sustained headache relief in ED migraine patients treated with metoclopramide.
• The study provides Class I evidence suggesting that 16 mg IV dexamethasone is not superior to 4 mg IV dexamethasone for preventing migraine recurrence when given with metoclopramide.